Family-based Screening and Treatment of Helicobacter Pylori:A Real World Study
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Studietype
Registrering (Forventet)
Registrering
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Li Yanqing, PhD
- Telefonnummer: 053182169385
- E-post: liyanqing@sdu.edu.cn
Studer Kontakt Backup
- Navn: Li Yueyue, PhD
- Telefonnummer: 18560089751
- E-post: lyynqj@126.com
Studiesteder
-
-
Shandong
-
Jinan, Shandong, Kina, 250012
- Rekruttering
- Department of Gastroenterology,Qilu Hospital,Shandong University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Community population over 3 years old who signed the informed consent.
- at least 2 people in the family.
- living together for at least 10 months each year in the past 5 years except child aged below 5.
Exclusion Criteria:
- PPI drugs such as esomeprazole、pantoprazole、 rabeprazole,、lansoprazole、famotidine and H2 receptor antagonists were taken within two weeks.
- antibiotics、bismuth agents or traditional Chinese medicine with antibacterial effect were taken within four weeks
- There are other factors that researchers think are not suitable for participation
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: Familiebasert
- Tidsperspektiver: Potensielle
Antall grupper / kohorter
Kohorter og intervensjoner
Gruppe / KohortGruppe / Kohort |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Family members in the study
Community groups that meet the inclusion criteria
|
Patients with positive Helicobacter pylori infection were determined by carbon 13 breath test ,The diagnosis and treatment of positive patients were followed up without other intervention.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Patient compliance of performing medical examination.
Tidsramme: 1 year
|
Good compliance of medical examination advice was defined as the subjects took the medical advice given by the doctor and the rate of adoption and implementation of the medical examination advice.
|
1 year
|
|
Patient compliance of taking medication
Tidsramme: 1 year
|
Patient compliance of taking medication is defined as the ratio of the actual dose of medication taken by the patient to the total amount of medication required by the prescription.
Good medication compliance is defined as the ratio greater than 80%.
|
1 year
|
|
Number of participants with treatment-related adverse events as assessed by CTCAE v5.0
Tidsramme: 1 year
|
Adverse reactions related to medication were recorded
|
1 year
|
|
Lesion detection ratio
Tidsramme: 1 year
|
The lesion detection ratio was defined as the ratio of the number of subjects who underwent medical examination on the basis of doctor's recommendation and were finally diagnosed with lesion to the number of subjects who underwent examination.
|
1 year
|
|
Eradication rate
Tidsramme: 1 year
|
Eradication rate was defined as the ratio of the number of patients diagnosed positive on the carbon 13 breath test to the number of subjects who turned negative after taking the eradication drug to the number of subjects diagnosed positive before taking the drug.
|
1 year
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
The high-risk factors of Helicobacter pylori infection in families were investigated by questionnaire statistics.
Tidsramme: 1 year
|
Questionnaire survey was used to conduct information statistics on families undergoing Helicobacter pylori screening.Statistics include family members of the general situation, basic information, personal health and life habit, individual disease history, personal nearly 1 month medications, family health and lifestyle, family history, history of HP infection and the eradication of history, screening results, doctor give opinions and patient adherence and follow-up outcome after screening process, etc. Statistical soft ware was used to analyze factor correlations.
|
1 year
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Studiestol: Li Yanqing, PhD, Qilu Hospital, Shandong University
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Forventet)
Primær fullføring
Studiet fullført (Forventet)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
Andre studie-ID-numre
- 2019SDU-QILU-186
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .